Home > Insider Trading > Filing (0001140361-13-038733)

Filing Details

Accession Number:: 0001140361-13-038733
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-15 18:04:08
Reporting Period:: 2013-10-10

Filing Date:: 2013-10-15
Accepted Time:: 2013-10-15 18:04:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1323974	Mwi Veterinary Supply Inc.	MWIV	Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)	020620757

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1333281	Jr F James Cleary	3041 W. Pasadena Dr. Boise ID 83705	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-10	1,100	$154.92	98,900	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-10	3,108	$155.90	95,792	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-10	4,559	$156.78	91,233	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-10	2,685	$157.83	88,548	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-10	101	$158.67	88,447	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-11	6,558	$155.66	81,889	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-11	5,359	$156.29	76,530	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-11	840	$157.29	75,690	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-14	300	$154.87	75,390	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2013-10-14	390	$156.20	75,000	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	111,942	Direct
Common Stock, Par Value $0.01 Per Share	1,895	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	1,895	Indirect	See footnote

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Rebholtz Descendants Trust on September 10, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.40 to $155.39, inclusive. Mr. Cleary has provided to MWI Veterinary Supply, Inc. (the "Company") and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.50 to $156.08, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.50 to $157.20, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.53 to $158.50, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.00 to $155.98, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.00 to $156.74, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.18 to $157.55, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.75 to $155.10, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.99 to $156.38, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Held by The Rebholtz Descendents Trust for the benefit of Mr. Cleary's family and certain other persons. Mr. Cleary expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.
Held by Teresa Cleary Children's Trust FBO Barbara Cleary for the benefit of one of Mr. Cleary's children. Mr. Cleary expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.
Held by Teresa Cleary Children's Trust FBO Abigail Cleary for the benefit of one of Mr. Cleary's children. Mr. Cleary expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.